Cresco Labs Inc. (CRLBF)

Market Cap	455.92M
Revenue (ttm)	661.62M
Net Income (ttm)	-52.19M
Shares Out	n/a
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,887,671
Average Volume	1,978,375
Open	1.335
Previous Close	1.200
Day's Range	1.280 - 1.490
52-Week Range	0.426 - 2.300
Beta	1.89
RSI	54.81
Earnings Date	Mar 12, 2026

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,900
• Stock Exchange: OTCMKTS
• Ticker Symbol: CRLBF

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.